The Value of Pragmatic Trials to Regulators
There rarely exists a one-size-fits-all solution. It is true socially, politically and it is certainly true in healthcare especially when Read More
Mastering Colony Stimulating Factor Use among Lung Cancer Patients Receiving Chemotherapy
It’s up to oncologists and their patients to make many, often tough, treatment decisions. For those treating patients receiving chemotherapy, Read More
A Real-World Solution for an Unsustainable Health System
The BIO International Conference presents the global biotech industry with many growth opportunities. From BIO programs and initiatives to BIO Read More
The Value of Pragmatic Trials to Clinicians
A reliance on real-world evidence for optimal decisions Clinicians are always striving to improve the quality and the precision of Read More
A New Day in Healthcare Research
On May 20th, the international HEOR community of roughly 4,000 stakeholders from more than 80 countries will fill the Hynes Read More
The Value of Pragmatic Trials to Life Science Product Developers
The need for higher levels of real-world evidence Healthcare stakeholders are increasingly demanding higher levels of real-world evidence. As the Read More
HealthCore: 20 Years of Real-World Evidence
CT Scans in Pediatric Patients with Headache While headaches are very common in children and adolescents, many parents fear the Read More
HealthCore: 20 Years of Real-World Evidence
Opioid Use Among Adolescent Patients Treated for Headache HealthCore has been developing actionable real-world evidence (RWE) for regulators, payers and Read More
HealthCore: 20 Years of Real-World Evidence
A Series of Studies Impacting Healthcare This July, we celebrated our 20th anniversary as a real-world research company.  Having worked Read More
Three Things to Know for AMCP Nexus 2016
Labor Day signals the end of summer.  Thoughts turn to going back to school, and keeping ourselves and our family Read More
HealthCore Awarded PCORI Funding
Everywhere you look is evidence of the power of collaboration.  By bringing different entities together, we can accomplish things that Read More
Real-World Evidence: Enriching the Gold Standard
For the past 50 years, Randomized Clinical Trials (RCT’s) have been a staple of pre-approval research; often referred to as Read More
Real-World Evidence Generation: Overcoming Concerns
Real-World Evidence (RWE) is a term that’s been around for many years, but as our team was reminded at ISPOR, Read More
A Guide to ISPOR DC
I look forward to the ISPOR Annual Meeting every year.  Apparently, I am not the only one, as several colleagues Read More
Accelerating Cures: Addressing Need While Avoiding Risk
The Annual International Meeting for ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, presents much like a “buffet” of Read More
How HealthCore Got Started: Part II
Claims data was the critical starting point for HealthCore. As an ‘index’ of the individual’s exposure to the healthcare system, Read More
The Policy-Changing Power of a Payer-Pharma Collaboration
Last week I traveled to Arizona for a senior level team strategy session. As part of our “break,” we set Read More
How HealthCore Got Started
My wife and I recently came across a box of photos from 20 years ago—We had a great laugh about Read More
Association of Strategic Alliance Professionals (ASAP) Recap
Last week I witnessed the alliance partnering “Super Bowl.” Hundreds of alliance management executives from around the world gathered in Read More
Real-Word Evidence (RWE): Twenty Years in the Making
HealthCore’s mission, to help provide clarity on the clinical and economic value of different treatment modalities—has never been more relevant. Read More